Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2013-12-20 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is a disclosure return filed by a listed issuer, Uni-Bio Science Group Limited, reporting changes in issued share capital and share buybacks. It includes detailed information on share issues pursuant to exercise of warrants and confirms no share repurchases. The document references compliance with listing rules and provides a summary of share capital changes and repurchase activity. It is not a full financial report, earnings release, or management discussion, but a regulatory disclosure about capital changes. This fits the definition of a Share Issue/Capital Change announcement (SHA). The document length is over 6000 characters and contains substantive data on share capital changes, not merely an announcement of a report publication or certification. Therefore, the correct classification is SHA with high confidence.
2013-12-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2013
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30 November 2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange rules. It is not an annual or interim report, earnings release, or management report. It is not a proxy, AGM material, or voting result announcement. The document fits best under the category of Share Issue/Capital Change (SHA), as it reports on share capital movements and related share issuance activities.
2013-12-05 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is a disclosure return filed by a listed issuer, Uni-Bio Science Group Limited, reporting changes in issued share capital and share buybacks. It includes detailed data on share issues and repurchases pursuant to specific listing rules of the Hong Kong Stock Exchange. The document is a regulatory disclosure about capital changes rather than a financial report or earnings release. It does not contain financial statements or management discussion but focuses on share capital changes and repurchase activity. This fits the definition of a Share Issue/Capital Change announcement (SHA). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive disclosure of capital changes.
2013-11-29 English
GRANT OF SHARE OPTIONS
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the grant of share options to directors and other eligible grantees under the company's share option scheme. It includes details such as the number of options granted, exercise price, validity period, and specific allocations to directors. The document references compliance with Listing Rules and is a formal disclosure of a share-based compensation event. This fits the category of a capital or financing update related to share option grants, which is a change in capital structure or equity incentives. The document is not a full financial report, earnings release, or management discussion, but a specific announcement about share options granted. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content support a high confidence in this classification.
2013-11-27 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 25 NOVEMBER 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from an Extraordinary General Meeting (EGM) held on 25 November 2013. It details the voting outcomes on resolutions related to share issuance mandates and share option scheme renewal. The text explicitly states it is announcing the results of shareholder votes at the EGM. The document length is 4039 characters, which is relatively short and consistent with an announcement rather than a full report. There is no detailed financial data or comprehensive report content, only voting results. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2013-11-25 English
Interim Report 2013
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2013' and contains detailed unaudited condensed consolidated financial statements for the six months ended 30 September 2013, including income statement, statement of financial position, cash flows, changes in equity, segment information, and notes. It explicitly states it is an interim report prepared under HKAS 34 'Interim Financial Reporting'. The length is substantial (15,000 characters) and contains actual financial data and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2014
2013-11-20 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.